Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2004 Aug 25;4 Suppl 1(Suppl 1):S26.
doi: 10.1186/1472-6874-4-S1-S26.

Gender Differences in Bacterial STIs in Canada

Affiliations

Gender Differences in Bacterial STIs in Canada

Thomas Wong et al. BMC Womens Health. .

Abstract

HEALTH ISSUE: The incidence of bacterial sexually transmitted infections (STIs) is rising in Canada. If these curable infections were prevented and treated, serious long-term sequelae including infertility, and associated treatment costs, could be dramatically reduced. STIs pose a greater risk to women than men in many ways, and further gender differences exist in screening and diagnosis. KEY FINDINGS: Reported incidence rates of chlamydia, gonorrhea, and infectious syphilis declined until 1997, when the trend began to reverse. The reported rate of chlamydia is much higher among women than men, whereas the reverse is true for gonorrhea and infectious syphilis. Increases in high-risk sexual behaviour among men who have sex with men were observed after the introduction of potent HIV suppressive therapy in 1996, but behavioural changes in women await further research. DATA GAPS AND RECOMMENDATIONS: STI surveillance in Canada needs improvement. Reported rates underestimate the true incidence. Gender-specific behavioural changes must be monitored to enhance responsiveness to groups at highest risk, and more research is needed on effective strategies to promote safer sexual practices. Geographic and ethnic disparities, gaps, and needs must be addressed. Urine screening for chlamydia should be more widely available for women as well as men, particularly among high-risk men in order to prevent re-infections in their partners. As women are more likely to present for health examinations (e.g. Pap tests), these screening opportunities must be utilized. Female-controlled methods of STI prevention, such as safer topical microbicides, are urgently needed.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Reported Chlamydia Rate per 100,000 Population in Canada, 1997–2000 Source: Sexual Health and Sexually Transmitted Infections, Centre for Infectious Disease Prevention and Control, Health Canada, 2001
Figure 2
Figure 2
Reported Chlamydia Rates in Canada Source: Sexual Health and Sexually Transmitted Infections, Centre for Infectious Disease Prevention and Control, Health Canada, 2001
Figure 3
Figure 3
Reported Gonorrhea Rate per 100,000 Population in Canada, 1997 to 2000. Source: Sexual Health and Sexually Transmitted Infections, Centre for Infectious Disease Prevention and Control, Health Canada, 2001
Figure 4
Figure 4
Reported Gonorrhea Rates in Canada Source: Sexual Health and Sexually Transmitted Infections, Centre for Infectious Disease Prevention and Control, Health Canada, 2001
Figure 5
Figure 5
Reported Infectious Syphilis Rate per 100,000 Population in Canada, 1997 to 2000 Source: Sexual Health and Sexually Transmitted Infections, Centre for Infectious Disease Prevention and Control, Health Canada, 2001
Figure 6
Figure 6
Reported Infectious Syphlis Rates in Canada Source: Sexual Health and Sexually Transmitted Infections, Centre for Infectious Disease Prevention and Control, Health Canada, 2001

Similar articles

Cited by

References

    1. Holmes KK, Stamm WE. Lower genital tract infection in females: urethro, cervical, and vaginal infections. In: Holmes KK, Sparling PF, Mardh P-A, Lemon SM, Stamm WE, Piot P, editor. Sexually transmitted diseases. New York: McGraw-Hill; 1999. pp. 761–782.
    1. Vickery BH, Bennett JP. The cervix and its secretion in mammals. Physiol Rev. 1968;48:135–154. - PubMed
    1. Harrison HR, Costin M, Meder JB, Bownds LM, Sim DA, Lewis M, et al. Cervical Chlamydia trachomatis infection in university women: relationship to history, contraception, ectopy, and cervicitis. Am J Obstet Gynecol. 1985;153:244–251. - PubMed
    1. Washington AE, Gove S, Schachter J, Sweet RL. Oral contraceptives, Chlamydia trachomatis infection, and pelvic inflammatory disease: a word of caution about protection. JAMA. 1985;253:2246–2250. doi: 10.1001/jama.253.15.2246. - DOI - PubMed
    1. Park BJ, Stergachis A, Scholes D, Heidrich FE, Holmes KK, Stamm WE. Contraceptive methods and the risk of Chlamydia trachomatis infection in young women. Am J Epidemiol. 1995;142:771–778. - PubMed